A prospective single centre, open label, pilot study to evaluate the safety of ICXP007 plus standard of care, for the treatment of lower extremity chronic, neuropathic diabetic foot ulcers
- Registry ID
- EUCTR2006-000692-15
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE2
- Sponsor
- Intercytex
- Start date
- 2006-04-27
- Completion date
- 2008-03-20
- Last update
- 2026-08-16
Conditions
Summary
The primary safety objective is to determine the safety of ICXP007 plus standard of care in the treatment of chronic diabetic foot ulcers. The primary efficacy objective is to determine the efficacy of ICXP007 plus standard of care in achieving complete ulcer closure at 12 weeks in chronic, neuropathic diabetic foot ulcers of greater than four weeks duration.
Locations
View on source registry